ANI PHARMACEUTICALS, INC (ANIP) Shareholder Equity
- 2026-06-30: Preferred Stock, Value, IssuedUSD $0.00; Common Stock, Value, IssuedUSD $3.00K; Additional Paid in CapitalUSD $620.25M; Treasury Stock, Common, ValueUSD $53.82M.
- 2026-03-31: Preferred Stock, Value, IssuedUSD $0.00; Common Stock, Value, IssuedUSD $3.00K; Additional Paid in CapitalUSD $608.43M; Treasury Stock, Common, ValueUSD $53.00M.
- 2025-12-31: Preferred Stock, Value, IssuedUSD $0.00; Common Stock, Value, IssuedUSD $3.00K; Additional Paid in CapitalUSD $596.04M; Treasury Stock, Common, ValueUSD $33.25M.
- 2025-09-30: Preferred Stock, Value, IssuedUSD $0.00; Common Stock, Value, IssuedUSD $3.00K; Additional Paid in CapitalUSD $586.23M; Treasury Stock, Common, ValueUSD $32.64M.
ANI PHARMACEUTICALS, INC Shareholder Equity
Filed components and totals, with each concept and unit kept separate. Components can overlap; they are not added together. Missing disclosures remain (m). Original concept pages retain their detailed breakdowns and history.
| Period end | Preferred Stock, Value, Issued USD | Common Stock, Value, Issued USD | Additional Paid in Capital USD | Treasury Stock, Common, Value USD | Accumulated Other Comprehensive Income (Loss), Net of Tax USD | Retained Earnings (Accumulated Deficit) USD | Stockholders' Equity Attributable to Parent USD | Treasury Stock, Common, Shares shares | Adjustments to Additional Paid in Capital, Equity Component of Convertible Debt USD | Treasury Stock, Value, Acquired, Cost Method USD | APIC, Share-based Payment Arrangement, Option, Increase for Cost Recognition USD | APIC, Share-based Payment Arrangement, Increase for Cost Recognition USD | Treasury Stock, Value USD | Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest USD | Common Stock, Value, Outstanding USD | Adjustments to Additional Paid in Capital, Convertible Debt with Conversion Feature USD | Adjustments to Additional Paid in Capital, Warrant Issued USD | Adjustments to Additional Paid in Capital, Income Tax Benefit from Share-based Compensation USD | Treasury Stock, Shares shares |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $0.00 | $3.00K | $620.25M | $53.82M | $-327.00K | $31.10M | $597.21M | 891.91K | (m) | 3 month · $813.00K 6 month · $20.57M | 6 month · $21.70M | 3 month · $11.51M | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2026-03-31 | $0.00 | $3.00K | $608.43M | $53.00M | $479.00K | $6.39M | $562.30M | 881.49K | (m) | 3 month · $19.75M | (m) | 3 month · $10.19M | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2025-12-31 | $0.00 | $3.00K | $596.04M | $33.25M | $1.03M | $-23.10M | $540.72M | 621.30K | (m) | 12 month · $12.21M | (m) | 12 month · $37.93M | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2025-09-30 | $0.00 | $3.00K | $586.23M | $32.64M | $2.81M | $-50.59M | $505.82M | 613.97K | (m) | 3 month · $1.04M 9 month · $11.60M | (m) | 3 month · $9.69M 9 month · $28.16M | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2025-06-30 | $0.00 | $2.00K | $541.90M | $31.59M | $3.31M | $-76.86M | $436.76M | 601.99K | (m) | 3 month · $551.00K 6 month · $10.55M | (m) | 3 month · $9.60M 6 month · $18.47M | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2025-03-31 | $0.00 | $2.00K | $531.05M | $31.04M | $3.61M | $-85.00M | $418.62M | 592.96K | (m) | 3 month · $10.00M | (m) | 3 month · $8.87M | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2024-12-31 | $0.00 | $2.00K | $519.65M | $21.04M | $5.34M | $-100.28M | $403.68M | 429.56K | 12 month · $-30.28M | 12 month · $10.96M | (m) | 12 month · $29.34M | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2024-09-30 | $0.00 | $2.00K | $510.90M | $20.72M | $5.37M | $-89.60M | $405.95M | 423.94K | 3 month · $-30.27M 9 month · $-30.27M | 3 month · $680.00K 9 month · $10.64M | (m) | 3 month · $7.48M 9 month · $22.28M | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2024-06-30 | $0.00 | $2.00K | $532.50M | $20.04M | $8.33M | $-65.03M | $455.76M | 412.59K | (m) | 3 month · $1.30M 6 month · $9.96M | (m) | 3 month · $7.86M 6 month · $14.80M | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2024-03-31 | $0.00 | $2.00K | $523.63M | $18.74M | $9.41M | $-62.33M | $451.96M | 392.96K | (m) | 3 month · $8.66M | (m) | 3 month · $6.93M | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2023-12-31 | $0.00 | $2.00K | $514.10M | $10.08M | $8.86M | $-80.13M | $432.75M | 263.94K | (m) | 12 month · $4.99M | (m) | 12 month · $20.65M | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2023-09-30 | $0.00 | $2.00K | $506.51M | $9.85M | $14.08M | $-80.88M | $429.86M | 259.55K | (m) | 3 month · $670.00K 9 month · $4.76M | (m) | 3 month · $5.44M 9 month · $15.03M | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2023-06-30 | $0.00 | $2.00K | $495.49M | $9.18M | $13.73M | $-90.41M | $409.62M | 248.36K | (m) | 3 month · $537.00K 6 month · $4.09M | (m) | 3 month · $5.25M 6 month · $9.59M | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2023-03-31 | (m) | $1.00K | $408.39M | $8.64M | $11.13M | $-96.25M | $314.63M | 233.52K | (m) | 3 month · $3.55M | (m) | 3 month · $4.34M | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2022-12-31 | $0.00 | $1.00K | $403.90M | $5.09M | $12.17M | $-97.29M | $313.69M | 149.03K | (m) | 12 month · $1.96M | (m) | 12 month · $14.60M | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2022-09-30 | (m) | $1.00K | $399.40M | $4.97M | $10.04M | $-92.64M | $311.82M | 145.85K | (m) | 3 month · $239.00K 9 month · $1.84M | (m) | 3 month · $3.87M 9 month · $10.86M | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2022-06-30 | (m) | $1.00K | $395.04M | $4.74M | $5.43M | $-83.63M | $312.11M | 139.11K | (m) | 3 month · $483.00K 6 month · $1.60M | (m) | 3 month · $3.76M 6 month · $6.99M | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2022-03-31 | (m) | $1.00K | $391.08M | $4.25M | $2.71M | $-68.30M | $321.24M | 122.71K | (m) | 3 month · $1.12M | (m) | 3 month · $3.24M | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2021-12-31 | (m) | $1.00K | $387.84M | $3.13M | $-3.06M | $-47.77M | $333.89M | 82.66K | (m) | 12 month · $889.00K | (m) | 12 month · $10.49M | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2021-09-30 | (m) | $1.00K | $222.21M | $3.13M | $-4.24M | $-23.44M | $191.40M | 82.66K | (m) | 3 month · $73.00K 9 month · $889.00K | (m) | 3 month · $2.81M 9 month · $7.52M | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2021-06-30 | (m) | $1.00K | $219.40M | $3.06M | $-5.43M | $-18.99M | $191.92M | 80.08K | (m) | 3 month · $468.00K 6 month · $816.00K | (m) | 3 month · $2.84M 6 month · $4.71M | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2021-03-31 | (m) | $1.00K | $216.22M | $2.59M | $-5.03M | $-4.89M | $203.71M | 86.03K | (m) | 3 month · $348.00K | (m) | 3 month · $1.87M | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2020-12-31 | (m) | $1.00K | $214.35M | $2.25M | $-11.44M | $-4.97M | $195.70M | 75.52K | (m) | 12 month · $1.52M | (m) | 12 month · $12.94M | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2020-09-30 | $0.00 | $1.00K | $211.79M | $2.25M | $-13.11M | $-1.34M | $195.10M | 75.52K | (m) | 9 month · $1.52M | (m) | 3 month · $2.38M 9 month · $10.54M | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2020-06-30 | $0.00 | $1.00K | $209.41M | $2.25M | $-14.05M | $-1.77M | $191.34M | 57.89K | (m) | 3 month · $1.03M 6 month · $1.52M | (m) | 3 month · $5.74M 6 month · $8.16M | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2020-03-31 | $0.00 | $1.00K | $203.50M | $1.21M | $-11.69M | $10.56M | $201.17M | 27.87K | (m) | 3 month · $488.00K | (m) | 3 month · $2.42M | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2019-12-31 | $0.00 | $1.00K | $200.80M | $723.00K | $-4.87M | $17.58M | $212.79M | 15.31K | (m) | 12 month · $1.03M | (m) | 12 month · $9.22M | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2019-09-30 | $0.00 | $1.00K | $197.47M | $723.00K | $-6.04M | $22.42M | $213.13M | 12.31K | (m) | 9 month · $1.03M | (m) | 3 month · $2.47M 9 month · $6.77M | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2019-06-30 | $0.00 | $1.00K | $194.87M | $723.00K | $-5.01M | $18.52M | $207.66M | 12.31K | (m) | 3 month · $723.00K 6 month · $1.03M | (m) | 3 month · $2.59M 6 month · $4.30M | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2019-03-31 | $0.00 | $1.00K | $189.97M | $0.00 | $-2.20M | $11.94M | $199.71M | 2.00K | (m) | 3 month · $308.00K | (m) | 3 month · $1.71M | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2018-12-31 | $0.00 | $1.00K | $186.81M | $659.00K | $-379.00K | $11.49M | $197.26M | 11.18K | (m) | 12 month · $659.00K | (m) | 12 month · $6.78M | (m) | (m) | (m) | 12 month · $-1.71M | (m) | (m) | (m) |
| 2018-09-30 | $0.00 | $1.00K | $186.53M | $659.00K | $533.00K | $6.06M | $192.47M | 11.18K | (m) | 9 month · $659.00K | (m) | 3 month · $1.79M 9 month · $4.95M | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2018-06-30 | $0.00 | $1.00K | $184.53M | $659.00K | $216.00K | $1.02M | $185.11M | 11.18K | (m) | 3 month · $409.00K 6 month · $659.00K | (m) | 3 month · $1.78M 6 month · $3.16M | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2018-03-31 | $0.00 | $1.00K | $181.65M | $250.00K | (m) | $-1.76M | $179.64M | 4.29K | (m) | 3 month · $250.00K | (m) | 3 month · $1.38M | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2017-12-31 | $0.00 | $1.00K | $179.02M | $259.00K | $0.00 | $-4.01M | $174.76M | 5.20K | (m) | 12 month · $259.00K | (m) | 12 month · $6.09M | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2017-09-30 | $0.00 | $1.00K | $177.44M | $259.00K | (m) | $5.62M | $182.80M | 5.20K | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2017-06-30 | $0.00 | $1.00K | $175.90M | $259.00K | (m) | $903.00K | $176.55M | 5.20K | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2017-03-31 | $0.00 | $1.00K | $173.99M | (m) | (m) | $-1.78M | $172.21M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2016-12-31 | $0.00 | $1.00K | $172.56M | $0.00 | (m) | $-2.92M | $169.65M | 0.00 | (m) | 12 month · $122.00K | (m) | 12 month · $6.07M | (m) | (m) | (m) | (m) | (m) | 12 month · $617.00K | (m) |
| 2016-09-30 | $0.00 | $1.00K | $170.66M | (m) | (m) | $-1.84M | $168.83M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2016-06-30 | $0.00 | $1.00K | $168.15M | (m) | (m) | $-4.38M | $163.78M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2016-03-31 | $0.00 | $1.00K | $165.68M | (m) | (m) | $-5.50M | $160.18M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2015-12-31 | $0.00 | $1.00K | $164.43M | (m) | (m) | $-4.35M | $160.08M | (m) | (m) | 12 month · $113.00K | (m) | 12 month · $3.86M | (m) | (m) | (m) | (m) | (m) | 12 month · $360.00K | (m) |
| 2015-09-30 | $0.00 | $1.00K | $163.12M | (m) | (m) | $-7.23M | $155.89M | (m) | (m) | (m) | (m) | (m) | $0.00 | (m) | (m) | (m) | (m) | (m) | 0.00 |
| 2015-06-30 | $0.00 | $1.00K | $161.40M | (m) | (m) | $-11.79M | $149.50M | (m) | (m) | (m) | (m) | (m) | $113.00K | (m) | (m) | (m) | (m) | (m) | 4.89K |
| 2015-03-31 | $0.00 | $1.00K | $160.09M | (m) | (m) | $-15.36M | $144.74M | (m) | (m) | (m) | (m) | (m) | $0.00 | (m) | (m) | (m) | (m) | (m) | 2.50K |
| 2014-12-31 | $0.00 | $1.00K | $159.51M | (m) | (m) | $-19.73M | $139.78M | (m) | (m) | (m) | (m) | 12 month · $3.42M | $0.00 | (m) | (m) | (m) | (m) | 12 month · $784.00K | 0.00 |
| 2014-09-30 | $0.00 | (m) | $140.22M | (m) | (m) | $-40.73M | $99.49M | (m) | (m) | (m) | (m) | (m) | $0.00 | (m) | (m) | (m) | (m) | (m) | 0.00 |
| 2014-06-30 | $0.00 | (m) | $139.07M | (m) | (m) | $-47.48M | $91.59M | (m) | (m) | (m) | (m) | (m) | $0.00 | (m) | (m) | (m) | (m) | (m) | 0.00 |
| 2014-03-31 | $0.00 | (m) | $137.27M | (m) | (m) | $-45.11M | $92.09M | (m) | (m) | (m) | (m) | (m) | $68.00K | (m) | (m) | (m) | (m) | (m) | 9.23K |
| 2013-12-31 | $0.00 | $1.00K | $89.50M | (m) | (m) | $-48.47M | $40.96M | (m) | (m) | 12 month · $433.00K | (m) | 12 month · $36.00K | $68.00K | (m) | (m) | (m) | (m) | 12 month · $0.00 | 9.23K |
| 2013-09-30 | (m) | (m) | $89.02M | (m) | (m) | $-51.90M | $36.69M | (m) | (m) | (m) | (m) | (m) | $432.56K | (m) | (m) | (m) | (m) | (m) | 59.09K |
| 2013-06-30 | (m) | (m) | $89.02M | (m) | (m) | $-53.10M | $35.49M | (m) | (m) | (m) | (m) | (m) | $432.56K | (m) | (m) | (m) | (m) | (m) | 59.09K |
| 2013-03-31 | (m) | (m) | (m) | (m) | (m) | $-247.25M | $26.03M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | $273.28M | (m) | (m) | (m) | (m) |
| 2012-12-31 | $0.00 | (m) | $1.08M | (m) | (m) | $-43.80M | $-42.72M | (m) | (m) | (m) | 12 month · $725.62K | (m) | $0.00 | (m) | $273.13M | (m) | (m) | (m) | (m) |
| 2012-09-30 | (m) | (m) | (m) | (m) | (m) | $-240.97M | $32.29M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | $273.26M | (m) | (m) | (m) | (m) |
| 2012-06-30 | (m) | (m) | (m) | (m) | (m) | $-234.85M | $30.92M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | $265.77M | (m) | (m) | (m) | (m) |
| 2012-03-31 | (m) | (m) | (m) | (m) | (m) | $-227.50M | $38.00M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | $265.50M | (m) | (m) | (m) | (m) |
| 2011-12-31 | (m) | (m) | (m) | (m) | (m) | $-217.24M | $-34.28M | (m) | (m) | (m) | 12 month · $1.18M | (m) | (m) | (m) | $255.05M | (m) | 12 month · $204.98K | (m) | (m) |
| 2011-09-30 | (m) | (m) | (m) | (m) | (m) | $-210.59M | $44.15M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | $254.74M | (m) | (m) | (m) | (m) |
| 2011-06-30 | (m) | (m) | (m) | (m) | (m) | $-197.86M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | $11.53M | $209.39M | (m) | (m) | (m) | (m) |
| 2010-12-31 | (m) | (m) | (m) | (m) | (m) | $-165.63M | $19.15M | (m) | (m) | (m) | 12 month · $992.76K | (m) | (m) | $19.15M | $184.78M | (m) | 12 month · $65.53K | (m) | (m) |
| 2009-12-31 | (m) | (m) | (m) | (m) | (m) | (m) | $15.83M | (m) | (m) | (m) | 12 month · $1.25M | (m) | (m) | (m) | (m) | (m) | 12 month · $64.10K | (m) | (m) |
| 2008-12-31 | (m) | (m) | (m) | (m) | (m) | (m) | $13.83M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| COMPASS Pathways plc (CMPS) | $1.812B | -4.87 | |
| Septerna, Inc. (SEPN) | United States | $1.783B | -63.01 |
| Xencor Inc (XNCR) | United States | $1.776B | -7.33 |
| Zymeworks Inc. (ZYME) | United States | $1.902B | -12.44 |
| Eton Pharmaceuticals, Inc. (ETON) | United States | $1.701B | 80.74 |
| Sarepta Therapeutics, Inc. (SRPT) | United States | $1.941B | -13.89 |
| AGIOS PHARMACEUTICALS, INC. (AGIO) | United States | $1.962B | -5.38 |
| Xeris Biopharma Holdings, Inc. (XERS) | United States | $1.632B | -80.10 |
| Stoke Therapeutics, Inc. (STOK) | United States | $1.630B | -9.82 |
| Biohaven Ltd. (BHVN) | United States | $1.990B | -3.83 |